Literature DB >> 24046064

LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.

Chao Gao1, Hao Pang, Xiao-Guang Luo, Yan Ren, Hong Shang, Zhi-Yi He.   

Abstract

The relation between the LRRK2 mutation and its effect on Parkinson's disease (PD) has always caught a lot attention. Recent studies found that the G2385R polymorphism of LRRK2 may increase the risk of PD in Asian populations. Here we tried to clarify the relationship between the LRRK2 G2385R variant and the clinical profiles including motor complication in Chinese PD patients. We identified the LRRK2 variant in the Chinese Han population in northern China and evaluated the relationship between the G2385R variant and clinical profiles through comparison between 36 carriers and 139 non-carriers. We found that G2385R carriers scored significantly higher in motor fluctuation and dyskinesia than non-carriers. Logistic regression analysis showed that the G2385R variant was an independent risk factor for motor fluctuation in females (odds ratio = 12.538, 95 % CI 2.216-70.942, P = 0.004), and a Chi-squared test showed that the frequency of dyskinesia tended to be higher in the carrier group compared to the non-carrier group (16 vs. 4.4 %, P = 0.050, OR = 4.127, 95 % CI 1.074-15.864). These findings indicate that the variant was closely related to the occurrence of motor complication. Additionally, the G2385R variant was significantly related to the early-onset of PD in female carriers (20.0 vs. 1.5 %, odds ratio = 16.25, 95 % CI 1.557-169.618, P = 0.020). Our study found that the G2385R variant was significantly associated with motor complications and that this variant was an independent risk factor for motor fluctuation in females. These findings provide the necessary preliminary data to better understand the unique profile of PD G2385R variant carriers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24046064     DOI: 10.1007/s00415-013-7086-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.

Authors:  Alessio Di Fonzo; Yah-Huei Wu-Chou; Chin-Song Lu; Marina van Doeselaar; Erik J Simons; Christan F Rohé; Hsiu-Chen Chang; Rou-Shayn Chen; Yi-Hsin Weng; Nicola Vanacore; Guido J Breedveld; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2006-04-22       Impact factor: 2.660

Review 2.  Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?

Authors:  Rachel Saunders-Pullman
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

3.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

4.  The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

Authors:  E K Tan; Y Zhao; L Skipper; M G Tan; A Di Fonzo; L Sun; S Fook-Chong; S Tang; E Chua; Y Yuen; L Tan; R Pavanni; M C Wong; P Kolatkar; C S Lu; V Bonifati; J J Liu
Journal:  Hum Genet       Date:  2006-09-30       Impact factor: 4.132

5.  The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.

Authors:  Cao Li; Zhang Ting; Xiao Qin; Wang Ying; Bai Li; Lu Guo Qiang; Ma Jian Fang; Zhang Jing; Ding Jian Qing; Chen Sheng Di
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

6.  Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.

Authors:  Kelly Claire Simon; Honglei Chen; Xiang Gao; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

7.  Caffeine, postmenopausal estrogen, and risk of Parkinson's disease.

Authors:  A Ascherio; H Chen; M A Schwarzschild; S M Zhang; G A Colditz; F E Speizer
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

8.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

9.  LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.

Authors:  Cyrus P Zabetian; Mitsutoshi Yamamoto; Alexis N Lopez; Hiroshi Ujike; Ignacio F Mata; Yuishin Izumi; Ryuji Kaji; Hirofumi Maruyama; Hiroyuki Morino; Masaya Oda; Carolyn M Hutter; Karen L Edwards; Gerard D Schellenberg; Debby W Tsuang; Dora Yearout; Eric B Larson; Hideshi Kawakami
Journal:  Mov Disord       Date:  2009-05-15       Impact factor: 10.338

10.  Premotor biomarkers for Parkinson's disease - a promising direction of research.

Authors:  Brian R Haas; Tessandra H Stewart; Jing Zhang
Journal:  Transl Neurodegener       Date:  2012-05-31       Impact factor: 8.014

View more
  7 in total

1.  CLOCK 3111T/C Variant Correlates with Motor Fluctuation and Sleep Disorders in Chinese Patients with Parkinson's Disease.

Authors:  Fan Lou; Ming Li; Xiaoguang Luo; Yan Ren
Journal:  Parkinsons Dis       Date:  2018-02-04

2.  The Association between LRRK2 G2385R and Phenotype of Parkinson's Disease in Asian Population: A Meta-Analysis of Comparative Studies.

Authors:  Wei Di; Zhiyong Zeng; Jingyan Li; Xiaoling Liu; Minzhi Bo; Hua Lv
Journal:  Parkinsons Dis       Date:  2018-07-10

3.  Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease.

Authors:  Shi-Shuang Cui; Rao Fu; Juan-Juan Du; Yi-Qi Lin; Pei Huang; Chao Gao; Hai-Yan Zhou; Sheng-Di Chen
Journal:  BMC Neurosci       Date:  2021-03-26       Impact factor: 3.288

4.  Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease.

Authors:  Toshiki Tezuka; Daisuke Taniguchi; Mariko Sano; Tomoyo Shimada; Yutaka Oji; Taiji Tsunemi; Aya Ikeda; Yuanzhe Li; Hiroyo Yoshino; Jun Ogata; Kahori Shiba-Fukushima; Manabu Funayama; Kenya Nishioka; Yuzuru Imai; Nobutaka Hattori
Journal:  NPJ Parkinsons Dis       Date:  2022-08-05

5.  Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.

Authors:  Qian Sun; Tian Wang; Tian-Fang Jiang; Pei Huang; Dun-Hui Li; Ying Wang; Qin Xiao; Jun Liu; Sheng-Di Chen
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

6.  Relationship between LRRK2 R1628P polymorphism and Parkinson's disease in Asian populations.

Authors:  Hui Zhao; Zhijun Kong
Journal:  Oncotarget       Date:  2016-07-26

7.  Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Li Shu; Yuan Zhang; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.